Abstract
One in six new HIV diagnoses in Europe occur among people over 50 years of age. As in the general population, the aging process is not homogeneous among older adults with HIV, and some of them exhibit impaired physical function, higher frailty and more frequent geriatric syndromes. These illness reflect a higher biological age independently of their chronological age. After starting antirretroviral treatment, people living with HIV (PLWH) older than 50 exhibit a poorer immunological recovery than younger PLWH. Moreover, older adults with HIV present early onset of comorbidities and functional impairment caused by persistent and chronic activation of the immune system, which leads to immune exhaustion and accelerated immunosenescence despite optimal suppression of HIV replication. The evidence of poorer immunological response to ARV, linked with early immunosenescence in PLWH and its prematurely deleterious effect in physiological functions and its clinical consequences, are the basis to accept the cut-off of 50 years of age to define an “older adult with HIV”.
Similar content being viewed by others
References
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13):853–860
Tavoschi L, Gomes Dias J, Pharris A (2017) New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004–15: an analysis of surveillance data. lancet HIV 4(11):e514–e521
Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A et al (2015) Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis 15(7):810–818
Trickey A, May MT, Vehreschild JJ, Obel N, Gill MJ, Crane HM, Boesecke C, Patterson S, Grabar S, Cazanave C, Cavassini M (2017) Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4(8):e349–e356
Wong C, Gange SJ, Moore RD, Justice AC, Buchacz K, Abraham AG et al (2018) Multimorbidity among persons living with human immunodeficiency virus in the United States. Clin Infect Dis 66(8):1230–1238
Lazar R, Kersanske L, Xia Q, Daskalakis D, Braunstein SL (2017) Hospitalization rates among people with HIV/AIDS in New York City, 2013. Clin Infect Dis 65(3):469–476
Khaw KT, Wareham N, Bingham S, Welch A, Luben R, Day N (2008) Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study. PLoS Med 5(1):e12
Horvath S, Levine AJ (2015) HIV-1 infection accelerates age according to the epigenetic clock. J Infect Dis 212(10):1563–1573
Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E et al (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53(11):1120–1126
Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M et al (2009) Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 50(3):299–306
Branas F, Jimenez Z, Sanchez-Conde M, Dronda F, Lopez-Bernaldo De Quiros JC, Perez-Elias MJ et al (2017) Frailty and physical function in older HIV-infected adults. Age Ageing 46(3):522–526
Greene M, Justice AC, Covinsky KE (2017) Assessment of geriatric syndromes and physical function in people living with HIV. Virulence 8(5):586–598
Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP (2014) Heterogeneity in healthy aging. J Gerontol Ser A 69(6):640–649
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217
Jylhava J, Pedersen NL, Hagg S (2017) Biological age predictors. EBioMedicine 21:29–36
Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14(10):R115
Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE et al (2015) DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 16:25
Christiansen L, Lenart A, Tan Q, Vaupel JW, Aviv A, McGue M et al (2016) DNA methylation age is associated with mortality in a longitudinal Danish twin study. Aging Cell 15(1):149–154
Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H (2016) Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenetics 8:64
Chen BH, Marioni RE, Colicino E, Peters MJ, Ward-Caviness CK, Tsai PC et al (2016) DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging 8(9):1844–1865
Gross AM, Jaeger PA, Kreisberg JF, Licon K, Jepsen KL, Khosroheidari M et al (2016) Methylome-wide analysis of chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA. Mol Cell 62(2):157–168
Nelson KN, Hui Q, Rimland D, Xu K, Freiberg MS, Justice AC et al (2017) Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive US veterans. AIDS 31(4):571–575
Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah E et al (2016) Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol 22(3):366–375
Greene M, Covinsky KE, Valcour V, Miao Y, Madamba J, Lampiris H et al (2015) Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr 69(2):161–167
Marioni RE, Shah S, McRae AF, Ritchie SJ, Muniz-Terrera G, Harris SE et al (2015) The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936. Int J Epidemiol 44(4):1388–1396
Bellizzi D, D’Aquila P, Montesanto A, Corsonello A, Mari V, Mazzei B et al (2012) Global DNA methylation in old subjects is correlated with frailty. Age 34(1):169–179
Schrack JA, Althoff KN, Jacobson LP, Erlandson KM, Jamieson BD, Koletar SL et al (2015) Accelerated longitudinal gait speed decline in HIV-infected older men. J Acquir Immune Defic Syndr 70(4):370–376
Brothers TD, Kirkland S, Guaraldi G, Falutz J, Theou O, Johnston BL et al (2014) Frailty in people aging with human immunodeficiency virus (HIV) infection. J Infect Dis 210(8):1170–1179
Centers for Disease Control and Prevention (1998) AIDS among persons aged greater than or equal to 50 years – United States, 1991–1996. MMWR 47:21–27
Manfredi R, Chiodo F (2000) A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14(10):1475–1477
Knobel H, Guelar A, Valldecillo G, Carmona A, Gonzalez A, Lopez-Colomes JL et al (2001) Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 15(12):1591–1593
Viard JP, Mocroft A, Chiesi A, Kirk O, Roge B, Panos G et al (2001) Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 183(8):1290–1294
Grabar S, Kousignian I, Sobel A, Le Bras P, Gasnault J, Enel P et al (2004) Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 18(15):2029–2038
Yamashita TE, Phair JP, Munoz A, Margolick JB, Detels R, O’Brien SJ et al (2001) Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study. AIDS 15(6):735–746
Branas F, Berenguer J, Sanchez-Conde M, Lopez-Bernaldo de Quiros JC, Miralles P, Cosin J et al (2008) The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy. Am J Med 121(9):820–824
Blanco JR, Jarrin I, Vallejo M, Berenguer J, Solera C, Rubio R et al (2012) Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses 28(9):1000–1006
Gomez de la Camara A, Rubio Herrera MA, Gutierrez Fuentes JA, Gomez Gerique JA, del Campo J, Jurado Valenzuela C et al (2008) [1991–2004 follow-up of a Spanish general population cohort. Mortality and raising risk factors in the DRECE III Study (Diet and Risk of Cardiovascular Diseases in Spain)]. Revista espanola de salud publica. 82(4):415–423. Seguimiento de 1991 a 2004 de la mortalidad y los factores de riesgo emergentes en una cohorte de poblacion general espanola. Estudio Drece III (Dieta y Riesgo de Enfermedades Cardiovasculares en Espana)
Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M et al (2010) Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D Study. AIDS 24(10):1537–1548
Dawood H, Hassan-Moosa R, Zuma NY, Naidoo K (2018) Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa. BMC Infect Dis 18(1):168
Bunting E, Rajkumar C, Fisher M (2014) The human immunodeficiency virus and ageing. Age Ageing 43(3):308–310
Butt AA, Chang CC, Kuller L, Goetz MB, Leaf D, Rimland D et al (2011) Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Arch Intern Med 171(8):737–743
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE et al (2014) Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis 59(12):1787–1797
Buehring B, Kirchner E, Sun Z, Calabrese L (2012) The frequency of low muscle mass and its overlap with low bone mineral density and lipodystrophy in individuals with HIV—a pilot study using DXA total body composition analysis. J Clin Densitom 15(2):224–232
Desai S, Landay A (2010) Early immune senescence in HIV disease. Curr HIV/AIDS Rep 7(1):4–10
Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62:141–155
Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL et al (2013) Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs 27(1):5–16
Lagathu C, Cossarizza A, Bereziat V, Nasi M, Capeau J, Pinti M (2017) Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS 31(Suppl 2):S105–S119
Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S et al (2015) Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 373(9):795–807
Rickabaugh TM, Baxter RM, Sehl M, Sinsheimer JS, Hultin PM, Hultin LE et al (2015) Acceleration of age-associated methylation patterns in HIV-1-infected adults. PloS ONE 10(3):e0119201
Leung JM, Fishbane N, Jones M, Morin A, Xu S, Liu JC et al (2017) Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion. Aging 9(3):687–705
Horvath S, Stein DJ, Phillips N, Heany SJ, Kobor MS, Lin DTS et al (2018) Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents. AIDS 32(11):1465–1474
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MSC has received honoraria for the following: speaking at symposia organized on behalf of MSD, ViiV Healthcare and Gilead. FBB has received honoraria for the following: research grants from MSD, speaking at symposia organized on behalf of MSD and ViiV Healthcare; developing educational materials for MSD; and board membership from ViiV Healthcare. JDA has no conflict of interest. FD has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Sánchez-Conde, M., Díaz-Alvarez, J., Dronda, F. et al. Why are people with HIV considered “older adults” in their fifties?. Eur Geriatr Med 10, 183–188 (2019). https://doi.org/10.1007/s41999-018-0148-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41999-018-0148-x